Monday, December 9 2013 4:12 PM EST2013-12-09 21:12:19 GMT
Louisville, Ky (WDRB) Flyers are up in Nelson and Hardin counties to find Bella who has been missing for more than two weeks and the reward is a car. People have been searching for 3-year-old Golden RetrieverMore >>
Golden Retriever named "Bella" has been missing for more than two weeks.More >>
Tuesday, December 10 2013 12:09 PM EST2013-12-10 17:09:14 GMT
LOUISVILLE, Ky. (WDRB) -- This can't be good. The New York Times reports this morning that a group of Kentucky mothers, bent on getting basketball scholarships for their sons, has teamed with a productionMore >>
The New York Times reports that a group of Kentucky women is trying to pitch a new reality series: "Real Basketball Moms of Kentucky."More >>
Follow the WDRB Newsroom, Reporters and Anchors.More >>
Tweets from the WDRB Newsroom, Reporters and Anchors.More >>
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Pharmacyclics, Inc.
SUNNYVALE, Calif., Nov. 1, 2013 /PRNewswire/ -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC) today announced that it will hold a conference call and audio webcast to discuss financial results for its third quarter ended September 30, 2013 and recent developments after the NASDAQ Market closes on Thursday, November 7, 2013 at 4:30 p.m. ET.
Replay Number (Toll Free): (855) 859-2056 Replay Number (International): (404) 537-3406 Conference ID #: 92632034
A webcast replay will be available on the Pharmacyclics website for 30 days.
About Pharmacyclics Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medical healthcare needs; and to identify promising product candidates based on scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.
Presently, Pharmacyclics has three product candidates in clinical development and several preclinical molecules in lead optimization. The Company is committed to high standards of ethics, scientific rigor, and operational efficiency as it moves each of these programs to viable commercialization.
Pharmacyclics is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.